Atlas Trials

A 12 Week Safety And Efficacy Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients

Clinical trial NCT01204853 · TERMINATED

Trial details

NCT number
NCT01204853
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypertension, Pulmonary
Start date
2010-08-01
Primary completion
2010-11-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.